Parallel Advisors, LLC Vor Biopharma Inc. Transaction History

Parallel Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 28, 2022	SELL	$6.04 - $12.23 $2,995 - $6,066	-496 Closed	0 $0
Q4 2021 Jan 20, 2022	BUY	$11.32 - $18.02 $4,618 - $7,352	408 Added 463.64%	496 $6,000
Q3 2021 Nov 02, 2021	BUY	$12.24 - $20.38 $489 - $815	40 Added 83.33%	88 $1,000
Q2 2021 Aug 06, 2021	BUY	$18.65 - $38.78 $895 - $1,861	48 New	48 $1,000

55.7M

4.15M

364K

Ticker VOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,056,300
Market Cap $959M
Description
Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Parallel Advisors, LLC with notifications on news.